Autism Case Report: Cause and Treatment of “High Opioid Tone” Autism
Authors:
Open Access
- 24 May 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Psychology
- Vol. 12
Abstract
Introduction: Neurobiological systems engineering models are useful for treating patients. We show a model of “high opioid tone” autism and present a hypothesis about how autism is caused by administration of opioids during childbirth.Main Symptoms: Clinical diagnosis of autism in a 25 year old man was confirmed by a Social Responsiveness Scale (SRS) self-rating of 79, severe, and a Social Communications Questionnaire (SCQ-2) by the patient's father scoring 27. Cold pressor time (CPT) was 190 seconds—unusually long, consonant with the high pain tolerance of autism.Therapeutic Intervention and Outcomes: At naltrexone 50 mg/day SRS fell to 54 and SCQ-−2–9; both non-significant. CPT fell to 28, repeat 39 s. Improved relatedness was experienced ambivalently, understood as feelings never before experienced—causing pain. Non-compliance with naltrexone was followed by cutting open his palm and drinking alcoholically. Transference focused psychotherapy has helped him remain naltrexone—compliant while he works on issues of identity and relatedness.Conclusion: The model suggests studies that could be conducted to both prevent and treat this form of autism.Keywords
This publication has 18 references indexed in Scilit:
- Fibromyalgia, Autism, and Opioid Addiction as Natural and Induced Disorders of the Endogenous Opioid Hormonal System2014
- Cannabinoid and opioid interactions: Implications for opiate dependence and withdrawalNeuroscience, 2013
- The role of immune dysfunction in the pathophysiology of autismBrain, Behavior, and Immunity, 2012
- Depression: An Evolutionarily Conserved Mechanism to Terminate Separation Distress? A Review of Aminergic, Peptidergic, and Neural Network PerspectivesNeuropsychoanalysis, 2009
- Just What Lies “Beyond the Pleasure Principle”?Neuropsychoanalysis, 2008
- Brain Systems for the Mediation of Social Separation‐Distress and Social‐Reward Evolutionary Antecedents and Neuropeptide IntermediariesaAnnals of the New York Academy of Sciences, 1997
- Clinical Case Report: Opiate Antagonist and Event-Related Desynchronization in 2 Autistic BoysNeuropsychobiology, 1995
- Difference between plasma N- and C-terminally directed beta-endorphin immunoreactivity in infantile autismAmerican Journal of Psychiatry, 1994
- Naltrexone in Autistic Children: Behavioral Symptoms and Attentional LearningJournal of the American Academy of Child & Adolescent Psychiatry, 1993
- Naltrexone in Autistic Children: An Acute Open Dose Range Tolerance TrialJournal of the American Academy of Child & Adolescent Psychiatry, 1989